elderly patients

  •  

    Cellular Aging and the Development of Cancer

    With: Kaumudi Bhawe, PhD

    Cancer is so often a disease of older people that a whole medical field, “oncogeriatrics,” exists to address the topic. Deeper understanding of the links between cancer and aging could lead to better treatments. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, about the relationship between cancer and aging processes that occur in individual cells in our bodies—throughout our… Read more »

  •   George Lundberg, MD

    Article from Targeted Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Once bladder cancer has infiltrated the muscle wall in elderly patients, it becomes challenging to treat. New drugs and immunotherapies show some promise.

    Go to full article published by Targeted Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •  

    Emphasizing Oncogeriatrics

    With: Nicolò Matteo Luca Battisti, MD

    A Q&A with Nicolò Matteo Luca Battisti, MD, Medical Oncologist at The Royal Marsden NHS Foundation Trust, London, United Kingdom, and Chair of the Young Interest Group of the International Society of Geriatric Oncology (SIOG); nicolo.battisti@gmail.com Q: Everyone knows that the practice of pediatric oncology is very different from adult oncology. How does the growing field of oncogeriatrics differ from usual adult oncology? A:… Read more »

  •   George Lundberg, MD

    Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes: 

    Ageism (bias against the elderly) is a real issue in the selection of patients to be included in clinical trials. A new study demonstrates how such bias may harm the elderly with renal cell carcinoma.

    Go to full article published by Medical Xpress.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   Emma Shtivelman, PhD

    Excerpt:

    A new study from Helsinki University Hospital, University of Helsinki and the Finnish Cancer Registry shows that survival after glioblastoma has improved since the millennium. The improvement in survival was, however, modest in elderly patients, raising concerns whether current treatment strategies are optimal for this patient group.

    “Glioblastoma is the most common brain , and one of the deadliest cancers known. Unfortunately, there is no cure for these rapidly progressing tumors.”

    Go to full article published by Medical Xpress on Oct 16, 2018.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.